Preemptive therapy in immunocompromised hosts
- PMID: 1848680
- DOI: 10.1056/NEJM199104113241509
Preemptive therapy in immunocompromised hosts
Comment on
-
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.N Engl J Med. 1991 Apr 11;324(15):1005-11. doi: 10.1056/NEJM199104113241501. N Engl J Med. 1991. PMID: 1848679 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical